COMPARISON OF ANTI-HIV AND ANTI-HCV THERAPY COSTS IN THE CZECH REPUBLIC

被引：0
|
作者：
Stefancikova, I [1 ]
Mazel, T. [1 ]
Haluska, M. [1 ]
Chytilova, P. [1 ]
Strnadova, M. [1 ]
Mahovska, R. [1 ]
Vocelka, M. [1 ]
机构：
[1] State Inst Drug Control, Prague 10, Czech Republic
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN60
引用
收藏
页码：S649 / S649
页数：1
相关论文
共 50 条
  • [21] Investigation of the Prevalence of HBsAg, Anti-HCV, and Anti-HIV in a Prison in Turkey: A Point Prevalence Study
    Yilmaz, Esmeray Mutlu
    Bilgin, Melek
    Koksal, Zeynep Senturk
    Oruc, Muhammet Ali
    Tabak, Fehmi
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2023, 29 (03): : 119 - 123
  • [22] HBsAg, Anti-HBs, Anti-HCV and Anti-HIV Seroprevalence of the Patients Applied to Artvin State Hospital
    Inci, Ayse
    Okay, Murat
    Guven, Demirhan
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2013, 19 (01): : 41 - 44
  • [23] The ratio of HBsAg, anti-HCV and anti-HIV positivity in patients indicated for fiberoptic bronchoscopy before the procedure
    Gumus, Seyfettin
    Aydogan, Mehmet
    Deniz, Omer
    Gundogan, Alper
    Mert, Gurkan
    Tozkoparan, Ergun
    Bilgic, Hayati
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [24] Cost of Unnecessary Repeat Requesting of Tests for HBsAg, Anti-HCV and Anti-HIV Screening in a University Hospital
    Demiray, Tayfur
    Koroglu, Mehmet
    Karakece, Engin
    Ozbek, Ahmet
    Altindis, Mustafa
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2015, 21 (03): : 76 - 79
  • [25] Seropositivity Rates Of HBsAg, Anti-HCV, Anti-HIV in Outpatients in Izmir Ataturk Traning and Research Hospital
    Uzun, Berrin
    Gungor, Serdar
    Hakan, E. R.
    Pektas, Bayram
    Demirci, Mustafa
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2013, 19 (03): : 123 - 125
  • [26] Evaluation of LIAISON® XL System for HBsAg, and Anti-HCV and Anti-HIV/Ag p24
    De Paschale, Massimo
    Manco, Maria Teresa
    Belvisi, Luisa
    Cagnin, Debora
    Cerulli, Teresa
    Paganini, Alessia
    Arpino, Olivia
    Cianflone, Annalisa
    Agrappi, Carlo
    Mirri, Paola
    Clerici, Pierangelo
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (03) : 489 - 496
  • [27] Anti-HIV therapy
    Geraci, AP
    Di Rocco, A
    AIDS, 2000, 14 (13) : 2059 - 2061
  • [28] COMPARISON OF ANTI-HCV 1.0 AND 2.0
    HANSON, M
    TOLLY, J
    POLESKY, H
    TRANSFUSION, 1992, 32 (08) : S73 - S73
  • [29] Siirt Devlet Hastanesi'ne Basvuran Hastalarda HBsAg, Anti-HBs, Anti-HCV ve Anti-HIV Seroprevalansi
    Tunc, Nedim
    Eraydin, Hakan
    Cetinkaya, Emin
    Oduncu, Mehmet Kadir
    Toy, Seyhmus
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2011, 17 (01): : 7 - 11
  • [30] HBsAg, Anti-HCV, and Anti-HIV Seroprevalence Among Patients Presenting to a State Hospital between 2014 and 2018
    Bayindir Bilman, Fulya
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2019, 8
12345